E-LIB Suche - Ergebnisse für: Ljungcrantz, I.

1

IL-1RAP blockade reduces atherosclerosis and limits plaque ..:

Mulholland, M. ; Jakobsson, G. ; Ljungcrantz, I....
Atherosclerosis. 355 (2022) - p. 29 , 2022

Link: https://doi.org/10.1016/..

2

S100A9 blockade ameliorates cardiac dysfunction and reduces..:

Jakobsson, G ; Mulholland, M ; Grentzmann, A...
Cardiovascular Research. 118 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

3

Inhibition of S100A9 function has immunomodulatory and card..:

Jakobsson, G. ; Mulholland, M. ; Grentzmann, A....
Atherosclerosis. 355 (2022) - p. 37-38 , 2022

Link: https://doi.org/10.1016/..

4

CD4+CD56+ natural killer T‐like cells secreting interferon‐..:

Björkbacka, H. ; Berg, K. E. ; Manjer, J....
Journal of Internal Medicine. 279 (2015) 1 - p. 78-88 , 2015

Link: https://doi.org/10.1111/..

5

IL-25 expands innate lymphoid cells type 2 and inhibits ath..:

Fredrikson, G. Nordin ; Mantani, P.T. ; Dunér, P....
Atherosclerosis. 235 (2014) 2 - p. e150 , 2014

Link: https://doi.org/10.1016/..

6

Association between CD8+ T‐cell subsets and cardiovascular ..:

Kolbus, D. ; Ljungcrantz, I. ; Andersson, L....
Journal of Internal Medicine. 274 (2013) 1 - p. 41-51 , 2013

Link: https://doi.org/10.1111/..

7

Evidence for a role of regulatory T cells in mediating the ..:

Wigren, M. ; Kolbus, D. ; Dunér, P....
Journal of Internal Medicine. 269 (2010) 5 - p. 546-556 , 2010

Link: https://doi.org/10.1111/..

8

Treatment with apo B peptide vaccines inhibits atherosclero..:

Fredrikson, G. N. ; Björkbacka, H. ; Söderberg, I...
Journal of Internal Medicine. 264 (2008) 6 - p. 563-570 , 2008

Link: https://doi.org/10.1111/..

9

INHIBITION OF ATHEROSCLEROSIS BY APO B PEPTIDE VACCINES IN ..:

Fredrikson, G. ; Bjorkbacka, H. ; Ljungcrantz, I....
Atherosclerosis Supplements. 9 (2008) 1 - p. 38-39 , 2008

Link: https://doi.org/10.1016/..

10

Interleukin‐1 receptor antagonist is detectable in human ca..:

GOTTSÄTER, A. ; FORSBLAD, J. ; MÄTZSCH, T....
Journal of Internal Medicine. 251 (2002) 1 - p. 61-68 , 2002

Link: https://doi.org/10.1046/..

11

The presence of elafin, SLPI, IL1‐RA and STNFα RI in head a..:

Westin, U. ; Nyström, M. ; Ljungcrantz, I...
Mediators of Inflammation. 11 (2000) 1 - p. 7-12 , 2000

Link: https://doi.org/10.1080/..

12

The presence of elafin, SLPI, IL1-RA and STNFalpha RI in he..:

Westin, U ; Nyström, M ; Ljungcrantz, I..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781642. , 2002

Link: http://www.ncbi.nlm.nih...

13

Production of secretory leucocyte protease inhibitor (SLPI)..:

Nyström, M ; Bergenfeldt, M ; Ljungcrantz, I..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781797. , 1999

Link: http://www.ncbi.nlm.nih...

14

The presence of elafin, SLPI, IL1-RA and STNFα RI in head a..:

U. Westin ; M. Nyström ; I. Ljungcrantz..
http://dx.doi.org/10.1080/09629350210304. , 2002

Link: https://doi.org/10.1080/..

15

Ion energy distributions in reactive arc evaporation discha..:

Ivanov, I. ; Ljungcrantz, H. ; Hakansson, G...
Surface and Coatings Technology. 92 (1997) 1-2 - p. 150-156 , 1997

Link: https://doi.org/10.1016/..